LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Abbott Laboratories (ABT) Declares 0.40 Dividend, Record Date 1/15/2010 12/11/2009 10:28:58 AM
  • Credit Suisse Is Raising Abbott Laboratories (ABT) 2010 Estimate To 4.08 From 4.06 10/15/2009 10:01:29 AM
  • Credit Suisse Is Increasing Abbott Laboratories (ABT) 2009 Estimate To 3.70 From 3.67 10/15/2009 10:00:53 AM
  • Abbott Laboratories (ABT) Has Raised Its FY09 EPS Estimate To 3.70 - 3.72 From 3.65 - 3.70 10/14/2009 7:48:40 AM
  • Credit Suisse Is Raising Abbott Laboratories (ABT) 2010 Estimate To 4.06 From 4.01 10/6/2009 10:12:59 AM
  • Credit Suisse Is Raising Abbott Laboratories (ABT) 2009 Estimate To 3.67 From 3.65 10/6/2009 10:12:08 AM
  • Abbott Laboratories (ABT) Declares 0.40 Dividend, Record Date 10/15/2009 9/17/2009 1:20:51 PM
  • Credit Suisse Is Lowering Abbott Laboratories (ABT) 2010 Estimate To 4.01 From 4.02 7/16/2009 10:12:49 AM
  • Credit Suisse Is Cutting Abbott Laboratories (ABT) 2009 Estimate To 3.65 From 3.66 7/16/2009 10:12:23 AM
  • Abbott Laboratories (ABT) Declares 0.40 Dividend, Record Date 7/15/2009 6/12/2009 10:53:44 AM
  • Credit Suisse Is Lowering Abbott Laboratories (ABT) 2010 Estimate To 4.02 From 4.13 4/16/2009 11:23:20 AM
  • Credit Suisse Is Cutting Abbott Laboratories (ABT) 2010 Estimate To 4.13 From 4.21 3/27/2009 10:19:05 AM
  • Credit Suisse Is Lowering Abbott Laboratories (ABT) 2009 Estimate To 3.69 From 3.70 3/27/2009 10:18:21 AM
  • Abbott Laboratories (ABT) Declares 0.40 Dividend, Record Date 4/15/2009 2/20/2009 10:42:47 AM
  • Barclays Capital Reiterates Abbott Laboratories (ABT) At Overweight With $65 Price Target 1/22/2009 2:25:39 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap